Rashidul Alam Mahumud | Health Economics | Best Researcher Award

Posted on by AI Data Scientist

Dr. Rashidul Alam Mahumud | Health Economics | Best Researcher Award

Senior Lecturer of Health Economics/Senior Research Fellow at NHMRC Clinical Trials Centre, The University of Sydney, Australia

Dr. Rashidul Alam Mahumud is a seasoned academic and early-career researcher in health economics with a substantial track record in public health, clinical epidemiology, and economic evaluation. With a multi-disciplinary background and a broad research portfolio, his work primarily focuses on cancer care, chronic disease management, and precision medicine. He currently serves as a Senior Lecturer in Health Economics and Senior Research Fellow at the NHMRC Clinical Trials Centre, University of Sydney. Known for his productivity and scholarly impact, Dr. Mahumud has authored over 140 publications with more than 4,700 citations and an H-index of 34. His editorial appointments with Q1-ranked journals and participation in prestigious national and international committees underscore his global reputation in the field.

Profile

Google Scholar

Education

Dr. Mahumud’s academic journey is both diverse and impressive. He earned his PhD in Health Economics from the University of Southern Queensland in 2020, where his dissertation investigated the burden and economic implications of cancer in Australia. In 2024, he completed a Master of Cancer Science at the University of Melbourne, focusing on post-therapy complications among cancer patients and their economic impact. Earlier, he obtained an MPH in Health Economics and Clinical Epidemiology from Independent University, Bangladesh, and a Master’s and Bachelor’s degree in Statistics from the University of Rajshahi. This solid educational foundation equips him with the analytical and methodological expertise essential for interdisciplinary health research.

Experience

Dr. Mahumud’s academic and professional experience spans over a decade, encompassing roles in teaching, research, and public health institutions across Bangladesh and Australia. Since 2020, he has been affiliated with the University of Sydney, first as a Research Fellow and then as a Senior Lecturer. Prior to this, he held a postdoctoral fellowship at Western Sydney University, where he also contributed as a lecturer. His earlier experience includes working as a Health Economist at the internationally renowned icddr,b in Dhaka and as a faculty member in statistics and mathematics at the Asian University of Bangladesh. These experiences have provided him with a comprehensive understanding of both global and local health systems and economic challenges.

Research Interest

Dr. Mahumud’s research is driven by a commitment to enhancing healthcare value through economic evaluation, particularly in oncology and chronic disease management. He specializes in health technology assessment, economic modelling, and cost-effectiveness analysis. His research also extends into precision medicine, patient-centered care, and the use of artificial intelligence in clinical decision-making. His work in identifying biomarkers, understanding disease burden, and evaluating interventions has been pivotal in shaping healthcare strategies in both high-income and resource-limited settings. He is actively involved in grant-funded research projects worth over $11 million AUD and supervises several PhD and postgraduate students in health economics and clinical research.

Award

Dr. Mahumud’s work has been recognized through multiple awards for research excellence and publication quality. He has consistently published in top-tier journals such as The Lancet, JAMA Oncology, and BMC Medicine. His contributions to international collaborations like the Global Burden of Disease (GBD) study, as well as his role in major clinical trials, have cemented his status as a thought leader in the health economics community. His involvement as an assessor for the NHMRC and international panels like the Fund for Innovation in Development (FID) chaired by Nobel Laureate Esther Duflo further illustrates his standing in global health research.

Publication

Among his notable works are:

  1. Mahumud RA et al. (2025). “Economic evaluation of lymphadenectomy for metastatic melanoma: Evidence from EAGLE FM Trial.” Annals of Surgical Oncology. Cited by 9.

  2. Dahal PK et al., Mahumud RA (2025). “Cost-effectiveness of behavioral interventions for Type 2 diabetes.” BMC Medicine. Cited by 6.

  3. Mosharaf MP et al., Mahumud RA (2025). “Economic evaluation of delirium interventions.” SSM-Mental Health. Cited by 5.

  4. Shahjalal M et al., Mahumud RA (2025). “Cancer treatment costs in Bangladesh.” Journal of Cancer Policy. Cited by 4.

  5. Mahumud RA (2024). “Melanoma overdiagnosis cost implications.” British Journal of Dermatology. Cited by 11.

  6. Mahumud RA et al. (2023). “Chronic disease burden in Bangladesh.” PLoS ONE. Cited by 14.

  7. Mahumud RA et al. (2022). “Precision medicine for melanoma care.” Medical Journal of Australia. Cited by 18.

Conclusion

Dr. Rashidul Alam Mahumud stands out as a prolific and impactful researcher who bridges the disciplines of health economics, biostatistics, and clinical epidemiology. With a clear focus on improving healthcare value through evidence-based economic strategies, he contributes to advancing policy, clinical practice, and health systems research globally. His journey from Bangladesh to Australia reflects a deep-rooted commitment to public health and academic excellence. As an academic leader and collaborative scholar, he continues to influence the future of health economics and precision medicine through high-quality research, mentorship, and global engagement.